ArticlePolymers2023
Ballistic Response of a Glass Fiber Composite for Two Levels of Threat.
Article in Polymers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Review
- Article
- Influence of Resin Grade and Mat on Low-Velocity Impact on Composite Applicable in Shipbuilding.Polymers · 2025Article
- Fiber and Polymer Composites: Processing, Simulation, Properties and Applications II.Polymers · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper presents the behavior of composite panels based on glass fiber unidirectional fabrics and a bi-component epoxy resin under ballistic impacts that characterize two threat levels: FB2 and FB3, according to EN 1523:2004. The tested panels had characteristics kept in narrow ranges: thickness 18.26 ± 0.22 mm, mass ratio fabrics/panel 0.788 ± 0.015, surface density 27.51 ± 0.26 kg/m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.